Expression and Clinical Significance of Herpes Virus Entry Mediator (HVEM) in Breast Cancer

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Aron Goldhirsch, Eric P. Winer, Alan S. Coates et al. · Annals of Oncology · 2013 · 3.7K citations · Full text

Medicine, Oncology, Breast Oncology +10

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Roberto Salgado, Carsten Denkert, Sandra Demaria et al. · Annals of Oncology · 2014 · 3.1K citations · Full text

Medicine, Immunology, Oncology +16

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Sherene Loi, Stefan Michiels, Roberto Salgado et al. · Annals of Oncology · 2014 · 1.3K citations

Medicine, Immunology, Oncology +15

REporting recommendations for tumor MARKer prognostic studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · Breast Cancer Research and Treatment · 2006 · 811 citations

Medicine, Biostatistics, Oncology +16

Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2

Roberto Gennari, Sylvie Ménard, Francesco Fagnoni et al. · Clinical Cancer Research · 2004 · 511 citations · Full text

Medicine, Oncology, Pharmacology +17